World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 

Novotech CRO strengthens South Korean Clinical Capabilities

Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region, has further strengthened its presence in South Korea with two major hospitals joining the Novotech partnership program - bringing more quality investigators, KOLs, and up to 4 million patients.

The 900 bed Ulsan University Hospital (UUH), and the Hepatology Division in Gastroenterology, Department of Internal Medicine at the 1,778 bed Seoul National University Hospital (SNUH), have joined the Novotech CRO partnership program, further strengthening Novotech's clinical service capabilities in South Korea.

South Korea is a fast-growing destination for clinical studies with quality infrastructure, world-class medical and hospital facilities, and supportive rapid start-up regulations. South Korea was Asia's most active country in clinical research after China last year, with over 400 sites opened by biopharma companies.

Novotech is well established in Asia with offices in 11 countries and more than 550 staff, while 19 leading hospitals and medical facilities across the region have now joined the Novotech CRO clinical partnership program.

Novotech CEO Dr John Moller said biotech clients were increasingly running Phase I studies in Australia, benefiting from the 41% R&D tax credit, then moving to Asia for subsequent trials. "Having the same company that understands the study as it transitions into Asia is always reassuring for clients. Novotech uses the latest Oracle and Medidata technology, so seamlessly connects with global clinical partners."



About Novotech - https://novotech-cro.com/welcome
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials across the Asia Pacific region.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management.

© Scoop Media

 
 
 
World Headlines

 

Gordon Campbell: On Collective Punishment In Venezuela

Yemen, Venezuela, Iran, Gaza… beyond the particulars of their suffering, each of these countries currently share one thing in common: their ordinary citizens are being subjected to collective punishment, in order to bring about regime change. More>>

Widely Ignored Report: 40,000 Dead Venezuelans Under US Sanctions

A new report on April 25 by a respected think tank has estimated that US sanctions imposed on Venezuela in August 2017 have caused around 40,000 deaths... Additional sanctions imposed in January 2019 are likely to lead to tens of thousands of further deaths. More>>

ALSO:

Gordon Campbell: On The Left-Wing Victory In Spain

Portugal and Spain continue to be striking exceptions to the rise of rightwing populism in Europe, a fact that’s commonly explained by the relatively recent experience both countries have had of living under fascist regimes. (Franco in Spain, and Salazar in Portugal.)

That horrific past still seems very much alive in the minds of voters... More>>

Easter Bombings Kill Hundreds: UN, World Leaders Condemn Sri Lanka Attacks

More than 200 have been killed and hundreds injured by a series of explosions inside churches and hotels in Sri Lanka, as Christians gathered for services to celebrate Easter.. More>>

ALSO: